Aligos Therapeutics, Inc.

The momentum for this stock is not very good. Aligos Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Aligos Therapeutics, Inc..
Log in to see more information.

News

Are Medical Stocks Lagging  Aligos Therapeutics (ALGS) This Year?
Are Medical Stocks Lagging Aligos Therapeutics (ALGS) This Year?

Zacks Investment Research The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Aligos Therapeutics, Inc. (ALGS) one of those stocks right...\n more…

Aligos Therapeutics (NASDAQ:ALGS) Shares Gap Down to $11.94
Aligos Therapeutics (NASDAQ:ALGS) Shares Gap Down to $11.94

Ticker Report Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $11.94, but opened at $11.70. Aligos Therapeutics...\n more…

Aligos Therapeutics (NASDAQ:ALGS) Shares Gap Down to $13.16
Aligos Therapeutics (NASDAQ:ALGS) Shares Gap Down to $13.16

Ticker Report Shares of Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $13.16, but opened at $12.83. Aligos Therapeutics...\n more…

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Significant Decrease in Short Interest
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Significant Decrease in Short Interest

Ticker Report Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report) was the recipient of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling...\n more…

Aligos Therapeutics (NASDAQ:ALGS) Sees Large Volume Increase
Aligos Therapeutics (NASDAQ:ALGS) Sees Large Volume Increase

Ticker Report Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report) saw unusually-high trading volume on Thursday . Approximately 25,663 shares traded hands during mid-day trading, an increase of 64% from the...\n more…

Aligos Therapeutics, Inc. Forecasted to Earn Q3 2024 Earnings of ($4.40) Per Share (NASDAQ:ALGS)
Aligos Therapeutics, Inc. Forecasted to Earn Q3 2024 Earnings of ($4.40) Per Share (NASDAQ:ALGS)

Ticker Report Aligos Therapeutics, Inc. (NASDAQ:ALGS - Free Report) - Research analysts at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for shares of Aligos Therapeutics in a research note...\n more…